The Monoclonal Antibodies for COVID


Monoclonal Antibodies, designed to mimic the body’s natural immune response, are

available as a treatment for COVID-19 for patients at high risk of progression to severe

disease.


There are several approved treatments for coronavirus disease 2019 (COVID-19) in

hospitalized patients but few for patients who are not sick enough to be hospitalized.

Monoclonal antibodies are a new treatment for outpatients with COVID-19 who are at

risk of progression to severe disease.


For more info check it out right here.

0 comments